Skip to Content

Join the 'Giant Cell Arteritis' group to help and get support from people like you.

Giant Cell Arteritis News

Tocilizumab Beats Steroids for Controlling Blood Vessel Inflammation in Study

Posted 26 Jul 2017 by Drugs.com

WEDNESDAY, July 26, 2017 – The drug tocilizumab performs better than steroids in treating the most common form of blood vessel inflammation known as giant cell arteritis, a new study has shown. The phase 3 clinical trial of 251 patients confirmed that tocilizumab (Actemra) reduced symptoms and also the need for high-dose steroid treatment for the condition. Phase 3 clinical trials represent the ...

FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis

Posted 23 May 2017 by Drugs.com

May 22, 2017 – The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the first FDA-approved therapy, specific to this type of vasculitis. “We expedited the development and review of this application because this drug fulfills a critical need for patients with this serious ...

Actemra Approved for Certain Blood Vessel Inflammation

Posted 22 May 2017 by Drugs.com

MONDAY, May 22, 2017 – The injected drug Actemra (tocilizumab) has been approved by the U.S. Food and Drug Administration to treat adults with giant cell arteritis, an inflammation of the blood vessels (vasculitis). In a media release Monday, the FDA said this form of vasculitis mostly involves blood vessels of the head. Traditional therapy includes large doses of anti-inflammatory drugs called ...

Study Ties Shingles Virus to Dangerous Blood Vessel Disease in Elderly

Posted 18 Feb 2015 by Drugs.com

WEDNESDAY, Feb. 18, 2015 – New research links the virus behind chickenpox and shingles to a blood vessel condition that afflicts the elderly and can sometimes be deadly. The study doesn't prove that the so-called varicella zoster virus causes the condition, known as giant cell arteritis. But study author Dr. Don Gilden, a professor of neurology at the University of Colorado School of Medicine in ...

Ask a Question

Further Information

Related Condition Support Groups

Collagen Vascular Disease

Related Drug Support Groups

Actemra, infliximab, tocilizumab